Sunil Singhania’s Abakkus Emerging Opportunities fund on small and midcaps delivered 10.30 per cent while Prashant Khemka-led White Oak Capital also managed a 10 per cent return along with Samir Arora’s Helios Capital.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This